A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.

MongoDB shows bullish technicals but faces weakened fundamentals with declining growth. See why now may be the time to sell ...

The XRP price surged 10% in the last 24 hours to trade at $2.82 as of 09:27 p.m. EST on trading volume that soared 60% to ...

Discover the top crypto to buy now with insights on expert market trends, technical indicators, and investment opportunities ...

The media company plans to unveil six ETF and SMA products focusing on American manufacturing, energy, and crypto investments ...

A waiver of special management area rules for Lahaina wildfire survivors is expected to reduce rebuilding permit processing ...

The NZD/USD pair saw a mild decline on Monday, slipping to 0.5640 as selling pressure persisted. Despite previous attempts to ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...

EUR/USD remains steady above 1.0350 in the European trading hours on Wednesday. The pair trades with caution as US President ...